At a glance
Also known as
ACHR; AChR; Muscle nicotinic Acetylcholine Receptor Binding Antibody; ACHR Antibody; Myasthenia Gravis Antibodies
Why get tested?
To help diagnose myasthenia gravis (MG)
and to distinguish between MG and other conditions with similar symptoms; sometimes to monitor MG
When to get tested?
When you have symptoms that suggest MG, such as a drooping eyelid, double vision, difficulty chewing or swallowing, and/or weakness in specific muscles
A blood sample drawn from a vein in your arm
Test preparation needed?
What is being tested?
Acetylcholine receptor (ACHR) antibodies are autoantibodies produced by the that mistakenly target proteins called acetylcholine receptors that are located on skeletal muscle fibres. This test detects and measures ACHR antibodies in the blood.
Acetylcholine receptors function as "docking stations" for acetylcholine, a chemical substance (neurotransmitter) that transmits messages between nerve cells. Muscle movement starts when an impulse is sent down a nerve to the nerve ending, where it stimulates the release of acetylcholine. Acetylcholine travels across a microscopic gap between the nerve ending and a muscle fibre at the "neuromuscular junction." When it reaches the muscle fibre, it binds to one of many acetylcholine receptors and activates it, initiating muscle contraction.
ACHR antibodies impede communication between nerves and skeletal muscles, inhibit muscle contraction, and cause rapid muscle fatigue by preventing activation of the acetylcholine receptors. They do this in three major ways:
- When they bind to the receptors, the antibodies may initiate an inflammatory reaction that destroys them.
- The antibodies may sit on the receptors, preventing acetylcholine from binding.
- The antibodies may cross-link the receptors, causing them to be taken up into the muscle cell and removed from the neuromuscular junction.
The end result of this interference is the development of myasthenia gravis (MG), a chronic autoimmune disorder associated with the presence of these antibodies and with their effects on muscle control.
ACHR antibodies may be detected in different ways to determine which mechanism may be the problem in a particular individual, and the antibodies may be referred to as "binding," "blocking," or "modulating." However, the technique that measures "binding" is the most commonly performed and, generally speaking, it is rare for the other two tests to be positive without the "binding" test being positive as well. These other approaches may be useful when the doctor strongly suspects myasthenia gravis and the "binding" test is negative. These are not available in routine laboratories in Australia.
How is the sample collected for testing?
A blood sample is obtained by inserting a needle into a vein in the arm.
Is any test preparation needed to ensure the quality of the sample?
No test preparation is needed.
How is it used?
An acetylcholine receptor (ACHR) antibody test is used to help diagnose myasthenia gravis (MG) and to distinguish it from other conditions that may cause similar symptoms, such as chronic muscle fatigue and weakness.
ACHR antibodies hinder the action of acetylcholine, a chemical (neurotransmitter) that transmits messages between nerve cells. The antibodies do this in three major ways:
- "Binding" antibodies attach to the acetylcholine receptors on nerve cells and may initiate an inflammatory reaction that destroys them.
- "Blocking" antibodies may sit on the receptors, preventing acetylcholine from binding.
- "Modulating" antibodies may cross-link the receptors, causing them to be taken up into the muscle cell and removed from the neuromuscular junction.
Three different types of tests are available to determine which of these may be the problem in a particular individual. However, the test that measures "binding" antibodies is most commonly used because it is generally rare for the other two tests to be positive without the "binding" test being positive as well.
One or more of the ACHR antibody tests may be ordered as part of a panel of tests that may also include a striated muscle antibody test to help establish a diagnosis. Depending upon results, an anti-MuSK (muscle-specific kinase) antibody test may also be ordered.
The ACHR antibody test may be ordered initially as a baseline test and then as indicated to evaluate MG disease activity and/or response to therapy.
People with MG often have an enlarged gland and may have thymomas (typically tumours of the thymus). Located under the breastbone, the thymus is an active part of the during childhood but normally becomes less active after puberty. If a thymoma is detected, such as during a chest computed tomography (CT) scan done for a different reason, then an ACHR antibody test may sometimes be used to determine whether the person has developed these antibodies.
When is it requested?
The ACHR antibody test may be ordered when a person has symptoms that suggest MG, such as:
- Drooping eyelid
- Double vision
- Decreased eye movement control
- Difficulty swallowing, chewing, with choking, drooling and gagging
- Slurred speech
- Weak neck muscles
- Trouble holding up head
- Difficulty breathing
- Difficulty walking and an altered gait
- Specific muscle weakness but normal feelings/sensations
- Muscle weakness that worsens with sustained effort and improves with rest
When a person has been diagnosed with MG, an ACHR antibody test may be ordered occasionally to evaluate MG disease activity and/or response to therapy.
An ACHR antibody test may sometimes be ordered when a thymoma is detected.
What does the test result mean?
ACHR antibodies are not normally present in the blood. They are autoantibodies and their presence indicates an response.
If a person has ACHR antibodies and symptoms of MG, then it is likely that the person has this condition.
ACHR antibodies may be seen with some thymomas, in people who are being treated with drugs such as penicillamine, with some small cell lung cancers, with autoimmune liver disease, and with Lambert-Eaton myasthenic syndrome (a condition associated with interference with the release of acetylcholine from the nerve ending).
A negative test result does not rule out MG. Up to 50% of those with ocular MG (affecting only eye-related muscles) and about 10-15% of those with generalized MG will be negative for ACHR antibodies.
In general, the greater the quantity of ACHR antibody, the more likely a person is to have significant symptoms, but the test results cannot be used to evaluate the severity of symptoms in a specific person.
Is there anything else I should know?
Use of drugs such as succinylcholine can increase ACHR antibodies.
People who have MG are more likely to also have other autoimmune disorders, such as rheumatoid arthritis or systemic lupus erythematosus.
Up to 70% of those suspected to have generalised MG but negative for ACHR antibodies will be positive for Anti-MuSK (muscle-specific kinase) antibodies.
Recent radioactive treatments can interfere with testing.
Can myasthenia gravis (MG) be inherited?
As an autoimmune process, no. Some people may inherit a genetic defect that causes congenital myasthenic syndrome, a condition with similar symptoms.
Can MG be passed from one person to another?
MG is not contagious, but a pregnant woman with MG can pass some of her ACHR antibodies to her fetus. This can cause a newborn to have MG symptoms for several weeks after birth.
Can MG affect my heart?
No, the receptors for heart and smooth (digestive) muscles are different from skeletal muscles so they are not affected by the formation of ACHR binding antibodies.
Can this test be performed in my doctor's office?
No, it is specialised testing that is not offered by every laboratory. Your blood will likely need to be sent to a reference laboratory for testing.
How serious is MG?
Most people who have it can live a normal or near normal life with treatment and monitoring. One of the most serious complications is a respiratory myasthenic crisis that can occur when muscles that control breathing are weakened. This can be a medical emergency and often requires hospitalisation.
Is there anything I can do to prevent getting ACHR binding antibodies?
No, the cause of MG is not known and the condition is not preventable.
Should everyone have an acetylcholine receptor (ACHR) antibody test?
It is not intended for general screening purposes and most people will never need to have one done.
Related lab tests
Anti-MuSK (muscle-specific kinase) Antibody, Striated Muscle Antibody, Rheumatiod Factor, Thyroid Function Test, Antinuclear Antibody (ANA), Autoantibodies
More on this site
Conditions: Myasthenia Gravis
, Rheumatoid Arthritis
, Systemic Lupus Erythematosus
, Autoimmune Disorders
Elsewhere on the web
Better Health Channel - Myasthenia gravis
The Australian Myasthenic Association
MedlinePlus Medical Encyclopedia: Myasthenia gravis
Muscular Dystrophy Association: Myasthenia Gravis (US)
Myasthenia Gravis Foundation of America
Kelly, K. (Updated 2012 March 16). Acetylcholine Receptor Antibody. Medscape Reference [On-line information]. Available online at http://emedicine.medscape.com/article/2094601-overview#showall through http://emedicine.medscape.com. Accessed April 2013.
(© 1995–2013). Acetylcholine Receptor (Muscle AChR) Binding Antibody, Serum. Mayo Clinic Mayo Medical Laboratories [On-line information]. Available online at http://www.mayomedicallaboratories.com/test-catalog/Overview/8338 through http://www.mayomedicallaboratories.com. Accessed April 2013.
Haven, T. et. al. (2010) An Algorithm for Acetylcholine Receptor Antibody Testing in Patients with Suspected Myasthenia Gravis. Clinical Chemistry v 56 (6) 1028–1040 [On-line information]. Available online at http://www.clinchem.org/content/56/6/1028.full through http://www.clinchem.org. Accessed April 2013.
Sheth, K. (Updated 2011 June 18). Myasthenia gravis. MedlinePlus Medical Encyclopedia [On-line information]. Available online athttp://www.nlm.nih.gov/medlineplus/ency/article/000712.htm. Accessed April 2013.
Sheth, K. (Updated 2011 April 30). Acetylcholine receptor antibody. MedlinePlus Medical Encyclopedia [On-line information]. Available online athttp://www.nlm.nih.gov/medlineplus/ency/article/003576.htm. Accessed April 2013.
Hill, H. and Haven, T. (2012 August). Acetylcholine Receptor Antibody Testing, For confirmation and monitoring of autoantibodies in patients with myasthenia gravis. ARUP Technical Information [On-line information]. PDF available for download at http://www.aruplab.com/guides/ug/tests/iconpdf_127.pdf throughhttp://www.aruplab.com. Accessed April 2013.
(2009 December). Facts About Myasthenia Gravis, Lambert-Eaton Myasthenic Syndrome & Congenital Myasthenic Syndromes. Muscular Dystrophy Association [On-line information]. Available online at http://mda.org/publications/facts-about-myasthenia-gravis through http://mda.org. Accessed April 2013.
(Updated 2012 August 29). Neurology Myasthenia Gravis Reflexive Panel. The University of Iowa (UIHC) Department of Pathology Laboratory Services Handbook [On-line information]. Available online at http://www.healthcare.uiowa.edu/path_handbook/handbook/test3101.html through http://www.healthcare.uiowa.edu. Accessed April 2013.
(2013 April 21). Nuromuscular Junction: Myasthenia Gravis. Muscular Dystrophy Australia [On-line information]. Available online at http://www.mda.org.au/Disorders/NMJ/MG.asp through http://www.mda.org.au. Accessed April 2013.
(© 2012). Acetylcholine Receptor Antibodies. NHS Greater Glasgow and Clyde Information [On-line information]. Available online at http://www.nhsggc.org.uk/content/default.asp?page=s1470_1_2 through http://www.nhsggc.org.uk. Accessed April 2013.
(Reviewed 2011 December) Myasthenia Gravis and Acetylcholine Receptor Autoantibodies. Quest Diagnostics Technical Information [On-line information]. Available online at http://www.questdiagnostics.com/testcenter/testguide.action?dc=WP_MyastheniaGravis through http://www.questdiagnostics.com. Accessed April 2013.
(© 2012). Caring for Children and Supporting Adolescents with Myasthenia Gravis. Myasthenia Gravis Foundation of America [On-line information]. Available online at http://www.myasthenia.org/LinkClick.aspx?fileticket=ygJC0SZLVZ4%3d&tabid=84 through http://www.myasthenia.org. Accessed April 2013.
Pagana, K. D. & Pagana, T. J. (© 2011). Mosby's Diagnostic and Laboratory Test Reference 10th Edition: Mosby, Inc., Saint Louis, MO. Pg 6.
Kasper DL, Braunwald E, Fauci AS, Hauser SL, Longo DL, Jameson JL eds, (2005) Harrison's Principles of Internal Medicine, 16th Edition, McGraw Hill, Pp 2518-2521.
Last Review Date: May 16, 2022
Was this page helpful?